Finance

Beta
Lists
9267:TYO
Genky DrugStores Co Ltd
JP¥3 335,00
-1,62%
(-55,00) 1D
19 Jun., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 9267...
Open
JP¥3 340
High
JP¥3 395
Low
JP¥3 300
Mkt. cap
103,49 mjd
Avg. vol.
83,70 k
Volume
60,10 k
Dividend
0,39%
Quarterly dividend
JP¥3
Ex-dividend date
18 Jun. 2026
P/E ratio
13,03
52-wk high
JP¥5 460
52-wk low
JP¥3 175
EPS
JP¥256
Shares outstanding
15,48 m
No. of employees
2 k
Open
JP¥3 340
High
JP¥3 395
Low
JP¥3 300
Mkt. cap
103,49 mjd
Avg. vol.
83,70 k
Volume
60,10 k
Dividend
0,39%
Quarterly dividend
JP¥3
Ex-dividend date
18 Jun. 2026
P/E ratio
13,03
52-wk high
JP¥5 460
52-wk low
JP¥3 175
EPS
JP¥256
Shares outstanding
15,48 m
No. of employees
2 k
News stories
From sources across the web
About Genky DrugStores Co Ltd
CEO-
Employees1,84 k
FoundedApr. 1988
Headquarters-
Sector-
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
53,40 mjd
54,63 mjd
53,22 mjd
52,45 mjd
Cost of goods sold
42,29 mjd
43,49 mjd
42,29 mjd
41,91 mjd
Cost of revenue
42,29 mjd
43,49 mjd
42,29 mjd
41,91 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,50 mjd
8,37 mjd
8,13 mjd
8,32 mjd
Operating expense
8,30 mjd
8,37 mjd
8,13 mjd
8,32 mjd
Total operating expenses
50,58 mjd
51,86 mjd
50,42 mjd
50,24 mjd
Operating income
2,82 mjd
2,77 mjd
2,80 mjd
2,21 mjd
Other non operating income
95,00 m
209,00 m
145,00 m
188,00 m
EBT including unusual items
2,86 mjd
2,92 mjd
2,88 mjd
2,32 mjd
EBT excluding unusual items
2,85 mjd
2,92 mjd
2,88 mjd
2,32 mjd
Income tax expense
664,00 m
910,00 m
900,00 m
721,00 m
Effective tax rate
23,24%
31,16%
31,22%
31,05%
Other operating expenses
-
-
-
-
Net income
2,19 mjd
2,01 mjd
1,98 mjd
1,60 mjd
Net profit margin
4,11%
3,68%
3,73%
3,05%
Earnings per share
-
-
-
-
Interest and investment income
3,00 m
4,00 m
3,00 m
6,00 m
Interest expense
-64,00 m
-64,00 m
-66,00 m
-81,00 m
Net interest expenses
-61,00 m
-60,00 m
-63,00 m
-75,00 m
Depreciation and amortization charges
5,80 mjd
-
-
-
EBITDA
4,39 mjd
4,45 mjd
4,48 mjd
3,89 mjd
Gain or loss from assets sale
-
3,00 m
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more